Mangiferin enhances the sensitivity of human multiple myeloma cells to anticancer drugs through suppression of the nuclear factor κB pathway.
Takeda, Tomoya
Mangiferin enhances the sensitivity of human multiple myeloma cells to anticancer drugs through suppression of the nuclear factor κB pathway. [electronic resource] - International journal of oncology Jun 2016 - 2704-12 p. digital
Publication Type: Journal Article
1791-2423
10.3892/ijo.2016.3470 doi
Antineoplastic Agents--pharmacology
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Cell Cycle--drug effects
Cell Line, Tumor
Cell Proliferation--drug effects
Cell Survival--drug effects
Doxorubicin--pharmacology
Drug Synergism
Gene Expression Regulation, Neoplastic--drug effects
Humans
Melphalan--pharmacology
Multiple Myeloma--drug therapy
NF-kappa B--metabolism
Signal Transduction--drug effects
Vincristine--pharmacology
Xanthones--pharmacology
Mangiferin enhances the sensitivity of human multiple myeloma cells to anticancer drugs through suppression of the nuclear factor κB pathway. [electronic resource] - International journal of oncology Jun 2016 - 2704-12 p. digital
Publication Type: Journal Article
1791-2423
10.3892/ijo.2016.3470 doi
Antineoplastic Agents--pharmacology
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Cell Cycle--drug effects
Cell Line, Tumor
Cell Proliferation--drug effects
Cell Survival--drug effects
Doxorubicin--pharmacology
Drug Synergism
Gene Expression Regulation, Neoplastic--drug effects
Humans
Melphalan--pharmacology
Multiple Myeloma--drug therapy
NF-kappa B--metabolism
Signal Transduction--drug effects
Vincristine--pharmacology
Xanthones--pharmacology